U.S. Patent Office Grants Interim Extension to Treosulfan Patent

Summary

The United States Patent and Trademark Office has issued an order granting a one-year interim extension of the term of U.S. Patent No. 7,199,162, allowing the patent holder to continue using the Treosulfan product for an additional year. The extension applies to the patent, which covers the use of Treosulfan, a chemotherapy medication.